Stock ScreenerStock IdeasZen Ratings + Top Analysts
Stocks With a Zen Rating of A + Top Analyst consensus of Strong Buy + Large Upside in Target Price: May 2, 2025
The 2 best sources of winning stocks is the Zen Ratings and our analysis of Top Analysts from Wall Street. Now we have combined them together in a best of both worlds approach to find stocks with the best upside potential.

Zen Rating: A
Upside/Downside: Large Upside
Top Analysts Consensus: Strong Buy
Ticker
Company
Exchange
Industry
Zen Rating
Market Cap
Price
1d %
EBITDA
P/E
D/E
Country
DD Score
JD
JDCOM INC
NASDAQ
Internet Retail
A$47.46B$32.62-0.79%$8.21B8.62x1.61
China
50
RL
RALPH LAUREN CORP
NYSE
Apparel Manufacturing
A$13.89B$224.950.45%$1.17B20.05x1.79
United States
50
WIX
WIXCOM LTD
NASDAQ
Software - Infrastructure
A$9.52B$169.59-0.23%$131.22M68.11x-25.28
Israel
52
KBR
KBR INC
NYSE
Engineering & Construction
A$6.99B$52.81-0.13%$805.00M18.93x3.58
United States
48
BGC
BGC GROUP INC
NASDAQ
Capital Markets
A$4.37B$9.06-1.20%$349.41M34.85x2.80
United States
42
INGM
INGRAM MICRO HOLDING CORP
NYSE
Electronics & Computer Distribution
A$4.18B$17.78-1.17%$1.10B15.07x4.03
United States
27
BDC
BELDEN INC
NYSE
Communication Equipment
A$4.15B$103.110.35%$382.01M21.13x1.57
United States
44
SGHC
SUPER GROUP (SGHC) LTD
NYSE
Gambling
A$4.09B$8.12-0.12%$302.38M32.48x0.89
Guernsey
45
KMPR
KEMPER CORP
NYSE
Insurance - Property & Casualty
A$3.78B$59.12-0.95%$504.40M11.94x3.53
United States
34
PRIM
PRIMORIS SERVICES CORP
NYSE
Engineering & Construction
A$3.22B$59.97-2.15%$415.75M17.80x1.98
United States
49
CPRX
CATALYST PHARMACEUTICALS INC
NASDAQ
Biotechnology
A$2.95B$24.290.04%$254.32M17.60x0.17
United States
76
AMRX
AMNEAL PHARMACEUTICALS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
A$2.37B$7.66-1.16%$396.76M-20.16x-33.05
14
HURN
HURON CONSULTING GROUP INC
NASDAQ
Consulting Services
A$2.32B$134.79-0.85%$216.00M19.48x1.76
United States
45
TTMI
TTM TECHNOLOGIES INC
NASDAQ
Electronic Components
A$2.04B$20.02-1.96%$236.70M36.40x1.22
United States
51
LIVN
LIVANOVA PLC
NASDAQ
Medical Devices
A$2.01B$37.00-1.75%$202.51M31.62x0.90
United Kingdom
49
FINV
FINVOLUTION GROUP
NYSE
Credit Services
A$2.00B$7.910.64%$400.38M6.25x0.53
China
30
ARDT
ARDENT HEALTH PARTNERS INC
NYSE
Medical Care Facilities
A$1.82B$12.730.63%$485.56M8.01x3.04
United States
49
EXTR
EXTREME NETWORKS INC
NASDAQ
Communication Equipment
A$1.75B$13.16-1.20%-$62.41M-14.15x20.11
United States
10
ADEA
ADEIA INC
NASDAQ
Software - Application
A$1.32B$12.31-1.52%$206.51M20.86x1.77
United States
23
TASK
TASKUS INC
NASDAQ
Information Technology Services
A$1.26B$13.96-2.38%$155.89M26.85x0.92
United States
55
AHCO
ADAPTHEALTH CORP
NASDAQ
Medical Devices
A$1.15B$8.511.67%$667.61M13.73x1.85
United States
58
YEXT
YEXT INC
NYSE
Software - Infrastructure
A$860.10M$6.800.15%$169.00k-30.91x2.98
United States
16
EVER
EVERQUOTE INC
NASDAQ
Internet Content & Information
A$848.09M$23.740.04%$39.68M25.80x0.56
United States
61
PRO
PROS HOLDINGS INC
NYSE
Software - Application
A$812.45M$17.08-3.77%-$10.86M-39.72x-7.11
United States
12
HCKT
HACKETT GROUP INC
NASDAQ
Information Technology Services
A$709.79M$25.54-0.89%$48.51M23.65x0.66
United States
57
TREE
LENDINGTREE INC
NASDAQ
Financial Conglomerates
A$690.98M$51.59-2.70%$11.82M-16.43x6.05
United States
14
RBBN
RIBBON COMMUNICATIONS INC
NASDAQ
Telecom Services
A$566.71M$3.21-14.40%$55.03M-11.07x1.98
United States
18
NEXN
NEXXEN INTERNATIONAL LTD
NASDAQ
Advertising Agencies
A$325.52M$9.930.61%$106.15M9.74x0.58
Israel
41
TATT
TAT TECHNOLOGIES LTD
NASDAQ
Aerospace & Defense
A$311.36M$28.46-0.04%$18.29M26.35x0.46
Israel
39
PMTS
CPI CARD GROUP INC
NASDAQ
Credit Services
A$293.83M$26.14-0.95%$75.53M14.94x-10.82
United States
13
EXFY
EXPENSIFY INC
NASDAQ
Software - Application
A$270.58M$2.96-0.67%$6.54M-24.67x0.35
United States
28
QUAD
QUAD/GRAPHICS INC
NYSE
Specialty Business Services
A$241.42M$4.77-7.92%$143.30M-13.25x13.26
United States
16

Upgrade to Premium to View More

Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More

Already have a premium account? Sign In
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.